BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26633600)

  • 21. Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified.
    Grambauer N; Schumacher M; Beyersmann J
    Stat Med; 2010 Mar; 29(7-8):875-84. PubMed ID: 20213713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
    Zahar JR; Timsit JF; Garrouste-Orgeas M; Français A; Vesin A; Descorps-Declere A; Dubois Y; Souweine B; Haouache H; Goldgran-Toledano D; Allaouchiche B; Azoulay E; Adrie C
    Crit Care Med; 2011 Aug; 39(8):1886-95. PubMed ID: 21516036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model.
    Austin PC; Allignol A; Fine JP
    J Clin Epidemiol; 2017 Mar; 83():75-84. PubMed ID: 28088594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
    Austin PC; Steyerberg EW; Putter H
    Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive subdistribution hazards regression for competing risks data in case-cohort studies.
    Wogu AF; Li H; Zhao S; Nichols HB; Cai J
    Biometrics; 2023 Dec; 79(4):3010-3022. PubMed ID: 36606409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
    Nolan EK; Chen HY
    Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does appropriate empiric antibiotic therapy modify intensive care unit-acquired Enterobacteriaceae bacteraemia mortality and discharge?
    Pouwels KB; Van Kleef E; Vansteelandt S; Batra R; Edgeworth JD; Smieszek T; Robotham JV
    J Hosp Infect; 2017 May; 96(1):23-28. PubMed ID: 28434629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models.
    Austin PC; Putter H; Lee DS; Steyerberg EW
    Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008368. PubMed ID: 35098725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to handle mortality when investigating length of hospital stay and time to clinical stability.
    Brock GN; Barnes C; Ramirez JA; Myers J
    BMC Med Res Methodol; 2011 Oct; 11():144. PubMed ID: 22029846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Clinical Cohort Data Using Nested Case-control and Case-cohort Sampling Designs. A Powerful and Economical Tool.
    Ohneberg K; Wolkewitz M; Beyersmann J; Palomar-Martinez M; Olaechea-Astigarraga P; Alvarez-Lerma F; Schumacher M
    Methods Inf Med; 2015; 54(6):505-14. PubMed ID: 26108707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men.
    Nouri S; Mahmoudi M; Mohammad K; Mansournia MA; Yaseri M; Akhtar-Danesh N
    BMC Med Res Methodol; 2020 Jan; 20(1):17. PubMed ID: 31996148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tree-based models for survival data with competing risks.
    Kretowska M
    Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multilevel competing risks in the evaluation of nosocomial infections: time to move on from proportional hazards and even from hazards altogether.
    Muñoz A; Mongilardi N; Checkley W
    Crit Care; 2014 May; 18(3):146. PubMed ID: 25042281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence densities in a competing events analysis.
    Grambauer N; Schumacher M; Dettenkofer M; Beyersmann J
    Am J Epidemiol; 2010 Nov; 172(9):1077-84. PubMed ID: 20817786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study.
    Peronnet E; Venet F; Maucort-Boulch D; Friggeri A; Cour M; Argaud L; Allaouchiche B; Floccard B; Aubrun F; Rimmelé T; Thiolliere F; Piriou V; Bohé J; Cazalis MA; Barbalat V; Monneret G; Morisset S; Textoris J; Vallin H; Pachot A; Lepape A;
    Intensive Care Med; 2017 Jul; 43(7):1013-1020. PubMed ID: 28477143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival of adult trauma patients.
    Davidson GH; Hamlat CA; Rivara FP; Koepsell TD; Jurkovich GJ; Arbabi S
    JAMA; 2011 Mar; 305(10):1001-7. PubMed ID: 21386078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
    Austin PC; Fine JP
    Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are KISS data representative of German intensive care units? Statistical issues.
    Rücker G; Schoop R; Beyersmann J; Schumacher M; Zuschneid I
    Methods Inf Med; 2006; 45(4):424-9. PubMed ID: 16964360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data.
    Deslandes E; Chevret S
    BMC Med Res Methodol; 2010 Jul; 10():69. PubMed ID: 20670425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.